Axel Bolte serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Axel Bolte has executed 14 insider transactions totaling $846.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 1, 2025 involved transacting 423,926 shares valued at $1.7M.
Axel Bolte currently holds 22,088 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Axel Bolte has been a net buyer of PTCT stock. They have purchased $817.5K and sold $29.0K worth of shares.
Axel Bolte's most recent insider trade was on Jul 1, 2025, when they sold 423,926 shares at $4.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 11, 2023 | ISEE | $0 | Option Exercise | 14,588 | $N/A | Discretionary |
| Mar 31, 2023 | INZY | $10.6K | Award | 4,806 | $2.21 | Discretionary |
| Sep 30, 2022 | INZY | $7.6K | Award | 3,315 | $2.28 | Discretionary |
| May 11, 2022 | ISEE | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Apr 19, 2022 | INZY | $250.0K | Purchase | 67,750 | $3.69 | Discretionary |
| Jun 24, 2021 | INZY | $0 | Sale | 66,788 | $N/A | Discretionary |
| Jun 24, 2021 | INZY | $65.5K | Option Exercise | 66,788 | $0.98 | Discretionary |
| Dec 30, 2016 | OPHT | $29.0K | Sale | 6,000 | $4.83 | Discretionary |
| Jun 3, 2016 | OPHT | $199.4K | Purchase | 3,500 | $56.97 | Discretionary |
| Mar 30, 2015 | OPHT | $24.1K | Purchase | 500 | $48.27 | Discretionary |
| Sep 25, 2013 | OPHT | $44.0K | Purchase | 2,000 | $22.00 | Discretionary |
| Jun 25, 2013 | PTCT | $300.0K | Purchase | 20,000 | $15.00 | Discretionary |